raloxifene hydrochloride has been researched along with Atheroma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, J; Huo, S; Li, C; Li, S; Lin, J; Lin, L; Liu, T; Luo, P; Lv, J; Ma, H; Shi, W; Wang, M; Wang, Y; Yan, D; Zhang, C | 1 |
1 other study(ies) available for raloxifene hydrochloride and Atheroma
| Article | Year |
|---|---|
Raloxifene inhibits IL-6/STAT3 signaling pathway and protects against high-fat-induced atherosclerosis in ApoE
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cell Movement; Cell Survival; Cells, Cultured; Diet, High-Fat; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Interleukin-6; Male; Mice; Mice, Knockout; Plaque, Atherosclerotic; Raloxifene Hydrochloride; Rats; RAW 264.7 Cells; Signal Transduction; STAT3 Transcription Factor | 2020 |